99% Savings - Buy Just @1 Rs X
Glibenclamide (Glyburide) + Metformin + Pioglitazone is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Glibenclamide (Glyburide) + Metformin + Pioglitazone is used -
Severe
Moderate
Mild
Common
Is the use of Glibenclamide (Glyburide) + Metformin + Pioglitazone safe for pregnant women?
Glibenclamide (Glyburide) + Metformin + Pioglitazone may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Glibenclamide (Glyburide) + Metformin + Pioglitazone again without your doctor's advice.
Is the use of Glibenclamide (Glyburide) + Metformin + Pioglitazone safe during breastfeeding?
Glibenclamide (Glyburide) + Metformin + Pioglitazone can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Glibenclamide (Glyburide) + Metformin + Pioglitazone on the Kidneys?
Glibenclamide (Glyburide) + Metformin + Pioglitazone has very mild side effects on the kidneys.
What is the effect of Glibenclamide (Glyburide) + Metformin + Pioglitazone on the Liver?
Glibenclamide (Glyburide) + Metformin + Pioglitazone can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Glibenclamide (Glyburide) + Metformin + Pioglitazone on the Heart?
You may experience side effects on your heart after taking Glibenclamide (Glyburide) + Metformin + Pioglitazone. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Glibenclamide (Glyburide) + Metformin + Pioglitazone should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glibenclamide (Glyburide) + Metformin + Pioglitazone unless your doctor advises you to do so -
Is this Glibenclamide (Glyburide) + Metformin + Pioglitazone habit forming or addictive?
Glibenclamide (Glyburide) + Metformin + Pioglitazone does not cause addiction.
Interaction between Food and Glibenclamide (Glyburide) + Metformin + Pioglitazone
There is no information on the effects of taking Glibenclamide (Glyburide) + Metformin + Pioglitazone with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Glibenclamide (Glyburide) + Metformin + Pioglitazone
Taking [medicine] and alcohol at the same time may lead to mild side effects. Contact your doctor right away if you observe any side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glynase® PresTab® (micronized glyburide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033